Should you buy LINCOLN.BO stock?
Last updated:
Based on market data through , StockInvest.us rates Lincoln Pharmaceuticals Ltd. (LINCOLN.BO) as Hold/Accumulate with a technical score of -0.33 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation.
- Hold signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Down 13.27%
- Easy Tracking In The Watchlist
Lincoln Pharmaceuticals Ltd. stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session
(Market data through Aug 11, 2026)
The Lincoln Pharmaceuticals Ltd. stock price gained 0.277% on the last trading day (Tuesday, 11th Aug 2026), rising from ₹595.80 to ₹597.45. During the last trading day the stock fluctuated 3.41% from a day low at ₹585.60 to a day high of ₹605.55. The price has risen in 7 of the last 10 days and is up by 3.1% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 thousand more shares were traded than the day before. In total, 4 thousand shares were bought and sold for approximately ₹2.68 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.27% during the next 3 months and, with a 90% probability hold a price between ₹442.14 and ₹572.80 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
LINCOLN.BO Signals & Forecast
There are mixed signals in the stock today. The Lincoln Pharmaceuticals Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at ₹597.96 and ₹601.79. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Thursday, July 30, 2026, and so far it has risen 4.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Lincoln Pharmaceuticals Ltd. stock
Lincoln Pharmaceuticals Ltd. finds support from accumulated volume at ₹590.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹19.95 (3.41%) between high and low. For the last week, the stock has had daily average volatility of 3.28%.
Our recommended stop-loss: ₹569.28 (-4.71%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 8 days ago.)
Trading Expectations (LINCOLN.BO) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Lincoln Pharmaceuticals Ltd. to open at ₹596.20, and during the day (based on 14 day Average True Range), to move between ₹588.07 and ₹606.83, which gives a possible trading interval of +/-₹18.75 (+/-3.19%) up or down from last closing price. If Lincoln Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 3.19% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at ₹590.10 (1.23%) than the resistance at ₹611.40 (2.33%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Lincoln Pharmaceuticals Ltd. stock A Buy?
Lincoln Pharmaceuticals Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
-0.334
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - ₹596.20 ( 0.209%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LINCOLN.BO Performance
Trading levels for LINCOLN.BO
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 616.15 | 3.13% |
| R2 | 608.53 | 1.85% |
| R1 | 603.82 | 1.07% |
| Price | 597.45 | |
| S1 | 588.58 | -1.48% |
| S2 | 583.87 | -2.27% |
| S3 | 576.25 | -3.55% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 631.90 | 5.77% |
| R2 | 629.75 | 5.41% |
| R1 | 611.40 | 2.33% |
| Price | 597.45 | |
| S1 | 590.10 | -1.23% |
| S2 | 589.70 | -1.30% |
| S3 | 589.25 | -1.37% |
FAQ
Click here for our free guide on how to buy Lincoln Pharmaceuticals Ltd. Stock.
Buy LINCOLN